Skyscape Web Viewer : CURRENT Practice Guidelines In Primary Care : Table Index

View All
Table 10-1 Stages of Acute Kidney Injury
Table 13-1 Clinical Recommendations For Use of Professionally Applied or Prescription-Strength, Home-Use Topical Fluoride Agents For Caries Prevention in Patients At Elevated Risk of Developing Caries
Table 13-2 Recommended Fluoride Supplementation by Age and Fluoride Level in Community Water Supply
Table 13-3 Cutoffs For Pediatric Stage 1 Hypertension
Table 15-1 Cervical Cancer Screening Recommendations
Table 19-10 Impact of Health Behavior Management On Blood Pressure
Table 19-11 Lifestyle Modifications For Treatment of Hypertension
Table 19-12 Screening BP Values Requiring Further Evaluation
Table 19-1 Rate Control in Atrial Fibrillation: Beta-Blockers
Table 19-2 Rate Control in Atrial Fibrillation: Calcium Channel Blockers
Table 19-3 Rate Control in Atrial Fibrillation: Cardiac Glycosides
Table 19-4 Rate Control in Atrial Fibrillation: Antiarrhythmics
Table 19-5 Stroke Risk Stratification with the Chads2 and Cha2ds2-Vasc Scores
Table 19-6 Has-Bled Bleeding Risk Score For Warfarin Therapy
Table 19-7 Thromboembolic Risk Scores in Nonvalvular Atrial Fibrillation
Table 19-8 Comparing Warfarin with Doacs
Table 19-9 Diabetes Medications with Cardiovascular Benefits
Table 1 Recommended Child and Adolescent Immunization Schedule For Ages 18 Y or Younger, United States, 2023
Table 20-1 Palliative and End-of-Life Care: Pain Management.
Table 2-10 Caprini Risk Stratification Model
Table 21-1 Dosing and Monitoring of Antithyroid Drug Therapy
Table 21-2 Recommendations For Adjunctive Diabetes Therapies Complementary to Common Comorbidities
Table 21-3 International Panel Guideline On Selecting Sglt-2 Inhibitors or Glp-1 Receptor Agonists
Table 2-1 ASCVD Groups That Benefit From Statin Therapy
Table 22-1 Acute Otitis Media—approaches to Treatment
Table 22-2 Types of Sinusitis and Their Management
Table 2-2 Statin Intensity Drug Levels
Table 23-1 Acute Diarrhea Antibiotic Treatment Recommendations
Table 2-3 Statin-Associated Side Effects
Table 24-1 Responses to Abnormal Screening Results, Patients Age 25-65 Without Prior Anomaliesa